Tafuramycin A
Tafuramycin A, a Duocarmycin derivative, is a potent anticancer and parasite attenuating agent. Tafuramycin A can be used for triple-negative breast cancer (TNBC) and malaria infection research.
For research use only. We do not sell to patients.
- CAS No.: 494868-78-9
- Formula: C23H21ClN2O6
- Molecular Weight:456.88
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
All Parasite Isoforms
More
Biological Activity
|
Cell Line
|
Type | Value | Description | References |
|---|---|---|---|---|
| A549 | IC50 |
3.7 nM
Compound: 3
|
Cytotoxicity against human A549 cells after 4 days by MTT assay
Cytotoxicity against human A549 cells after 4 days by MTT assay
|
[PMID: 29548574] |
| A549 | IC50 |
53 nM
Compound: 3
|
Cytotoxicity against human A549 cells after 3 days by MTT assay
Cytotoxicity against human A549 cells after 3 days by MTT assay
|
[PMID: 29548574] |
| B16 | IC50 |
40 nM
Compound: 3
|
Cytotoxicity against mouse B16 cells after 3 days by MTT assay
Cytotoxicity against mouse B16 cells after 3 days by MTT assay
|
[PMID: 29548574] |
Chemical Information
-
CAS No. 494868-78-9
-
Molecular Weight 456.88
-
Formula C23H21ClN2O6
-
SMILES
O=C(N1C2=C(C(C1)CCl)C3=C(C=CO3)C(O)=C2)C4=CC5=C(N4)C(OC)=C(OC)C(OC)=C5
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Purity & Documentation
References
[1]. El-Deeb IM, et al. Selective Targeting of Breast Cancer by Tafuramycin A Using SMA-Nanoassemblies. Molecules. 2021 Jun 9;26(12):3532. [Content Brief]
[2]. El-Deeb IM, et al. A versatile synthesis of "tafuramycin A": a potent anticancer and parasite attenuating agent. Org Biomol Chem. 2014 Jun 28;12(24):4260-4. [Content Brief]
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)